A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Tunneling nanotubes (TNTs) are primarily open-ended F-actin membrane nanotubes that connect neighboring cells, facilitating intercellular communication. The notable characteristic that distinguishes TNTs from other cell protrusions is the hovering nature of the nanotubes between cells. Here, we characterize TNTs by constructing a 3D volume view of confocal z-stack images.

Abstract

Recent discoveries have revealed that cells perform direct, long-range, intercellular transfer via nano-scale, actin-membrane conduits, namely "tunneling nanotubes" (TNTs). TNTs are defined as open-ended, lipid bilayer-encircled membrane extensions that mediate continuity between neighboring cells of diameters ranging between 50 nm and 1 µm. TNTs were demonstrated initially in neuronal cells, but successive studies have revealed the existence of TNTs in several cell types and diseases, such as neurodegenerative diseases, viral infections, and cancer. Several studies have referred to close-ended, electrically coupled membrane nanostructures between neighboring cells as TNTs or TNT-like structures.

The elucidation of ultrastructure in terms of membrane continuity at the endpoint is technically challenging. In addition, studies on cell-cell communication are challenging in terms of the characterization of TNTs using conventional methods due to the lack of specific markers. TNTs are primarily defined as F-actin-based, open-ended membrane protrusions. However, one major limitation is that F-actin is present in all types of protrusions, making it challenging to differentiate TNTs from other protrusions. One of the notable characteristics of F-actin-based TNTs is that these structures hover between two cells without touching the substratum. Therefore, distinct F-actin-stained TNTs can conveniently be distinguished from other protrusions such as filopodia and neurites based on their hovering between cells.

We have recently shown that the internalization of oligomeric amyloid-β1-42 (oAβ) via actin-dependent endocytosis stimulates activated p21-activated kinase-1 (PAK1), which mediates the formation of F-actin-containing TNTs coexpressed with phospho-PAK1 between SH-SY5Y neuronal cells. This protocol outlines a 3D volume analysis method to identify and characterize TNTs from the captured z-stack images of F-actin- and phospho-PAK1-immunostained membrane protrusions in oAβ-treated neuronal cells. Further, TNTs are distinguished from developing neurites and neuronal outgrowths based on F-actin- and β-III tubulin-immunostained membrane conduits.

Introduction

Tunneling nanotubes (TNTs) are F-actin-based, primarily open-ended membrane conduits and play a vital role in the intercellular transfer of cargo and organelles1. The unique characteristic of TNTs is that they connect neighboring cells without any contact with the substratum; they are over 10-300 µm in length and their diameters vary between 50 nm to 1 µm2,3. TNTs are transient structures, and their lifetime lasts between a few minutes to several hours. TNTs were first demonstrated in PC12 neuronal cells1; later, numerous studies showed their existence in several cell types in vitro and in vivo4,5. Several studies have revealed the pathological significance of TNTs in various disease models, such as neurodegenerative diseases, cancer, and viral infections6,7,8.

The structural heterogeneities of TNTs have been demonstrated by several studies in various cellular systems9. The differences are based on cytoskeleton composition, the mechanism of formation, and the cargo types transferred10. Primarily, the open-ended, F-actin-positive membrane continuity that hovers between two neighboring cells and transfers organelles is considered to consist of TNTs11. However, the lack of clarity or diversity observed in the formation of TNTs adds to the difficulty in developing TNT-specific markers. Thus, it is difficult to identify TNT structures by conventional detection methods and distinguish membrane nanotubes in terms of open-ended and close-ended protrusions12. However, the characteristic of TNTs to hover as F-actin membrane protrusions between two cells is relatively easier and more feasible to identify using conventional imaging techniques. Other actin-based cellular protrusions such as filopodia and dorsal filopodia cannot hover between two distant cells, particularly when cells are fixed. Of note, close-ended, electrically coupled, developing neurites are often termed TNT-like structures13.

It is known that F-actin plays an important role in TNT formation, and several studies have shown that the F-actin inhibitor cytochalasin D inhibits the formation of TNTs14,15. In contrast, inhibitors of microtubules do not have any effect on TNT formation16. The last 2 decades have seen several reports on the significant role that TNTs play in the spread of pathology and tumor resistance and therapy17. Therefore, there is a never-ending demand for better techniques for TNT characterization.

The lack of specific markers of TNTs and the diversity in morphology and cytoskeletal composition make it difficult to develop a unique method of characterization. Some studies have used automated image detection and TNT quantification techniques18,19. However, there are several advantages of the present 3D volume manual analysis method over automatic image analysis for the detection and quantification of TNTs. Often, trained human eyes can spot these hovering nano-structures more easily than an automated image detection method. Moreover, automatic detection methods could be difficult to implement in laboratories lacking algorithm expertise. The present method could be widely adopted by researchers due to its precision and reproducibility.

In a recent study, we showed that oAβ promotes the biogenesis of TNTs in neuronal cells via a PAK1-mediated, actin-dependent, endocytosis mechanism12. oAβ-induced TNTs also express activated PAK1 (or phospho-PAK1). We developed a 3D volume view image reconstruction method to distinguish oAβ-induced, F-actin- and phospho-PAK1-immunostained TNTs. β-III tubulin-positive, developing neurites often resemble TNT-like hovering structures20. Hence, we further distinguished F-actin-based TNTs from β-III tubulin-positive neurites and other TNT-like protrusions. 3D volume view images have been used to identify TNTs on the basis of their characteristics of hovering over the substratum and staying connected between two neighboring cells. This paper describes the identification and detection of actin-containing membrane conduits or TNTs using confocal z-stack images and, finally, manual quantification of the identified structures from 3D volume view reconstruction images. The presented method cannot distinguish open-ended proper TNTs from close-ended TNT-like structures; this method helps identify TNTs in in vitro 2D cell culture on a flat substratum. However, the method is easy to implement and reproduce and can be widely used for the precise quantification of only actin-based TNTs and to distinguish them from neurites and β-tubulin positive TNT-like structures.

Protocol

NOTE: SH-SY5Y cells cultured in DMEM/F-12 media were differentiated with 10 µM retinoic acid for 7 days and treated with 1 µM oAβ oligomers for 2 h at 37 °C (5% CO2). After treatment, the cells were fixed with Karnovsky's fixative solution and double-immunostained with phospho-PAK1 (Thr423)/PAK2 (Thr402) antibody and F-actin-binding phalloidin. Later, confocal z-stack images were taken using a confocal laser scanning microscope. The TNTs were quantified by manual counting and distinguished from other neurites/cell protrusions by constructing 3D volume view images and identifying the structures from their characteristic of hovering between two cells without touching the substratum (Figure 1).

1. Cell culture and differentiation

  1. Culture the SH-SY5Y neuronal cells in DMEM/F12 (Ham's) media 1:1 with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin-neomycin mixture (PSN). Seed the cells in a 35 mm imaging dish with a 14 mm well made up of a #1.5 coverslip at the center of the dish attached to the bottom. Seed the cells on the imaging dish at a concentration of 12,000 cells/cm2 and perform the experiments at 60%-70% confluency.
  2. Partially differentiate the cells with 10 µM retinoic acid (RA) from a 100 mM stock solution (5 mg of RA in 15 mL of dimethyl sulfoxide [DMSO]). Then, incubate the cells for 7 days at 37 °C (5% CO2) for differentiation with media change every 2 days.
    NOTE: Be careful about maintaining the confluency (60%-70%) of the cells (both undifferentiated and partially differentiated cells). Cell density can influence the formation of TNTs between the cells.

2. Preparation of oligomers of amyloid-β1-42 (oAβ) to treat neuronal cells

  1. Dissolve Aβ1-42 (1 mg) in 200 µL of 1,1,1,3,3,3-hexafluoro-2-propanol and divide the solution into 20 aliquots, each containing 0.05 mg of peptides. Lyophilize and store the aliquots at −20 °C for later use.
  2. Prepare the stock solution (5 mM) of the lyophilized Aβ1-42 in DMSO by adding 2.2 µL of DMSO to 0.05 mg of lyophilized peptide. To carefully dissolve the peptides, vortex the solution and sonicate for 2 min in a water bath sonicator.
  3. Dilute the stock solution to a concentration of 100 µM in DMEM, pH 7.4, and vortex to convert the peptides to monomers, followed by incubation at 4 °C for 24 h to obtain oligomers of Aβ1-42 (oAβ)12,21,22.
  4. Characterize oAβ before the experiments as reported previously21,22 by transmission electron microscopy imaging.
  5. Treat the partially differentiated SH-SY5Y cells with 1 µM oAβ. Remove the medium before the treatments, and add fresh FBS-free DMEM. After the medium change, add previously prepared oAβ (100 µM) to the medium to a final concentration of 1 µM. Incubate the cells with 1 µM oAβ for 2 h at 37 °C (5% CO2). Include a negative control in the form of untreated cells.

3. Immunostaining of F-actin and activated-PAK1 for the characterization of TNTs

  1. Perform differential immunostaining by using phospho-PAK1 (Thr423)/PAK2 (Thr402) antibody and F-actin-binding phallotoxin phalloidin.
  2. Wash the control and oAβ-treated cells with 1x phosphate-buffered saline (PBS) for 2 x 2 min before fixation. Prepare the Karnovsky's fixative solution by using 2% formalin fixative and 2.5% glutaraldehyde dissolved in 0.1 M phosphate buffer, pH 7.2. Then, fix the cells in the imaging dish by adding Karnovsky's fixative solution (just enough to cover the cells) for 45 min at room temperature.
  3. Wash the fixed cells 2 x 2 min using incubation buffer. Prepare the incubation buffer (20x) by dissolving 0.1 g of saponin in 5 mL of FBS and dilute to 1x by adding 95 mL of 1x PBS.
  4. After fixation, add the first antibody against phopho-PAK1 at a dilution of 1:250 in the incubation buffer and incubate overnight at 4 °C in a dark moist chamber.
  5. The next day, after 24 h of incubation, wash the cells 2 x 2 min with the incubation buffer; then, add secondary antibody conjugated to Alexa Fluor 488 (1:1,000 dilution) and Phalloidin 555 (1:1,000 dilution). Incubate the cells in the dark moist chamber for 1.5 h at room temperature.
  6. After the incubation, wash the cells 2 x 2 min with incubation buffer. Stain the nucleus by adding 4',6-diamidino-2-phenylindole (DAPI) in a 1:2,000 dilution and incubate for 5 min to 10 min at room temperature in the dark.
  7. Prepare DABCO mounting medium using 25 mg of DABCO in 90% glycerol and 10% 1x PBS. To dissolve properly, adjust the pH to 8.6 using spectrophotometric grade, dilute HCl (diluted 1:20 with water) and keep the solution on a rocker for mixing.
  8. As an anti-bleaching agent, add the DABCO mounting medium directly onto the imaging dish containing the coverslip at the bottom. Wait for at least 1-2 h and directly proceed to perform confocal imaging.
    NOTE: No adhesives are required to fix the coverslips.

4. Immunostaining of F-actin and β-III tubulin to distinguish TNTs from neurites

  1. Perform differential immunostaining with β-III tubulin antibody and F-actin-binding phallotoxin phalloidin.
  2. Wash the oAβ-treated cells 2x with 1x PBS before adding Karnovsky's fixative solution. Incubate the cells for 45 min at room temperature and wash the cells 2 x 2 min with incubation buffer.
  3. After fixation, add the antibody against β-III tubulin (TUBb3) at a dilution of 1:250 in the incubation buffer and incubate at 4 °C overnight in the dark moist chamber.
  4. The next day, wash the cells with incubation buffer (2 x 2 min), and add secondary antibody conjugated to Alexa Fluor 488 (1:1,000 dilution) and Phalloidin 555 (1:1,000 dilution) together to the same dish. Then, incubate the cells for 1.5 h at room temperature in the dark moist chamber.
  5. Wash the cells 2x with incubation buffer, and add nuclear-staining DAPI in a 1:2,000 dilution for 5-10 min at room temperature in the dark.
  6. Add anti-bleaching agent DABCO in mounting medium as mentioned above and wait for 2 h before imaging.

5. Imaging with confocal microscopy

  1. To identify TNTs, capture z-stack images of immunostained cells using a confocal laser scanning microscope. Take the images using 40x/1.40 Oil DIC objective with DAPI, fluorescein isothiocyanate (FITC), and tetramethylrhodamine (TRITC) filter sets.
  2. First, select the channels by clicking the required lasers sequentially in the windows Track 1, Track 2, and Track 3 in the confocal software. Click the option T-PMT below the Track 1 window to take the differential interference contrast (DIC) images with fluorescence channels.
    NOTE: DIC images are captured by a different detector labeled as T-PMT.
  3. Select the acquisition tab of the software, click on the Z-stack tab, and wait for a window to open. Then, click live scan to focus the cells at the bottom of the dish. Select that focused image as the first stack. Then, focus up to see the topmost part of the cell and select that as the last stack. Stop live scanning and click the number next to the optimal tab to fix the step size of the stacks. Step size determines the number of slices and the intervals based on the thickness of the cells.
    NOTE: Step size will be selected based on Nyquist sampling to take enough slices and ensure there are no gaps between the two stacks. Nyquist sampling is determined on the basis of the objective and the wavelengths of the lights23.
  4. Take sequential images of three channels of DAPI, FITC, and TRITC with 405 nm, 488 nm, and 561 nm lasers and capture with a pixel dwell time of 1.02 µs. Capture images in the DIC channel with fluorescence channels to observe the cell boundary.
  5. Capture a stack of images with the dimensions of x: 224.92 µm and y: 224.92 µm, with each pixel of 220 nm2 size and z-scaling of 415 nm.
  6. Take images capturing several z-stacks (15-22 stacks) from the bottom to the top of the cells. Acquire at least 10 images from the random field of the culture dish to get a total of ~200-300 cells.
  7. Analyze the captured images offline to identify the TNTs by 3D volume view analysis

6. Analysis of confocal z-stack images to identify and quantify TNTs

  1. Open the confocal images saved in .czi data format in Fiji software for analysis.
  2. Select the Hyperstack option to see each z-stack and channel of the image. Look for the hyperstacks of the z-stacks and channels, which open in a single window as shown in Figure 2. Scroll the channel (indicated by red and green arrows) and z-stack (indicated by blue arrows) scroll bars to select the exact stack of a particular channel of interest.
    NOTE: In fixed cells, as the hovering TNTs or membrane conduits stay above the surface, the structures are not visible in the lower parts of the z-stacks. However, in fixed cells, neurites lie on the surface and are detectable in the lower parts of the z-stacks (z = 0 to 2). See Figure 2 for the identification steps.
  3. As shown in Figure 2, select the F-actin-stained channel (indicated by red arrows) first by scrolling the channel bar. Then, manually scroll the z-stacks (indicated by blue arrows) to see each stack one by one. Identify the F-actin-stained structures that seem to be connecting cells, are visible in the lower parts of the z-stacks, and are close to the surface of the imaging dish (z = 2) as neurites (indicated by white arrows).
    NOTE: The majority of the neurites are easy to identify as they appear as extended protrusions (indicated by pink arrows).
  4. Identify the TNTs, the F-actin-positive, hovering cell-to-cell conduits, by scrolling the z-stacks toward the top (from z = 4 in Figure 2; indicated by yellow arrows). Look for neurites near the lower parts of the z-stacks toward the surface and observe that they start disappearing with the scrolling of z-stacks toward the top (at z = 6 in Figure 2; neurites are not clearly visible).
  5. Identify phospho-PAK1-positive TNTs similarly as F-actin-positive TNTs by analyzing the hovering nature of the conduits from the z-stacks. As phospho-PAK1 staining is weaker than F-actin staining, look for phopho-PAK1-stained TNTs at z = 4 (faintly visible)and at z = 6 (prominent).
  6. Further, observe the DIC images to verify that the F-actin- and phospho-PAK1-stained TNT structures are membrane conduits between cells (Figure 3). In addition, merge F-actin (red) and phospho-PAK1 (green) channels to verify that the identified TNTs are F-actin and phospho-PAK1 co-stained structures (Figure 3).
  7. To quantify the TNTs, count the total cell numbers and the identified TNTs manually and represent the numbers as percentages.
  8. To distinguish F-actin-positive TNTs and β-III tubulin (TUBb3)-positive, TNT-like hovering conduits from z-stack images, merge F-actin (red) and TUBb3 (green) channels (Figure 4). Then, analyze the z-stacks of the merged images.
    1. Look for exclusively F-actin-stained TNTs that are faintly visible at z = 3 and prominent at z = 6 and z = 9 (yellow arrows). Similarly, identify F-actin and β-III tubulin (TUBb3) double-positive, TNT-like hovering conduits at z = 6 and z = 9 (cyan arrows). Identify other F-actin- and β-III tubulin-stained, non-hovering protrusions from the lower parts of the z-stacks (white arrows).
  9. Measure the diameter of the TNTs using the line tool in Fiji. Verify the scale of measurement by clicking Analyze | Set Scale so that "distance in pixels" is set automatically from the .czi images. Measure the diameters of the TNTs at the xy-plane.
    NOTE: Most of the diameters are between 1 pixel and 4 pixels (i.e., 220-880 nm); each pixel is 220 nm. See Figure 5 for a summary of the protocol for the analysis of z-stack confocal images.

7. 3D reconstruction of z-stack images to characterize TNTs

  1. Use the volume viewer plugin in Fiji, which allows 3D reslicing and threshold-enabled 3D visualization (Figure 6).
  2. Split the z-stack images into individual channels. Then, crop the single-channel (F-actin channel) z-stack images to use 3D reconstruction view to highlight one or two TNTs or neurites at a time. Enable the volume view plugin to visualize xy, yz, and xz views.
  3. Pin a single TNT or neurite in the xy plane (white arrows represent neurites in Figure 6A; yellow arrows represent TNTs in Figure 6B) and mark xz (red) and yz (green) axis cross-sections. Observe the neurites at the bottom of the xz plane in the xz and yz planes (white arrows, Figure 6A) and the TNTs in the upper z-stacks (yellow arrows, Figure 6B).
  4. Select the individual TNT or neurite to reconstruct the 3D volume view in the xz-plane (Figure 6C, D). In the 3D reconstruction, observe the neurites at the bottom of the z-plane (white arrows, Figure 6C) and the TNTs appearing as hovering structures connecting two cells without touching the bottom z-plane (yellow arrows, Figure 6D).

Results

Here, we identify and characterize oAβ-induced TNTs in SH-SY5Y neuronal cells by constructing 3D volume views from confocal z-stack images (Figure 1). The cells were double-immunostained with F-actin and phospho-PAK1. Confocal z-stack images of immunostained cells were analyzed to identify TNTs (Figure 2). Further, DIC images were analyzed to verify that the F-actin- and phospho-PAK1-stained TNT structures were membrane conduits between cells (

Discussion

Several researchers in the past 2 decades have been trying to understand and characterize the structure of TNTs18. The lack of specific markers hinders progress, and there is an increasing demand for a convenient, standardized method that can be used to identify, characterize, and quantify TNTs. TNTs are defined as F-actin-based membrane conduits that hover between two cells. Studies have shown that β-tubulin-positive, close-ended, developing neurites hover between two distant cells and resem...

Disclosures

The authors have no conflict of interest to disclose.

Acknowledgements

D.K.V and A.R thank the Manipal Academy of Higher Education for the TMA Pai fellowship. We thank the Science and Engineering Research Board of India for SERB-SRG (#SRG/2021/001315), as well as the Indian Council of Medical Research of India (#5/4-5/Ad-hoc/Neuro/216/2020-NCD-I) and the Intramural fund of Manipal Academy of Higher Education, Manipal, India. We thank JNCASR's (Jawaharlal Nehru Centre for Advanced Scientific Research, India) confocal facility and B. Suma for the confocal microscopy in JNCASR.

Materials

NameCompanyCatalog NumberComments
35 mm dish with 14 mm well size made of #1.5 cover slipCellvisD35-14-1.5-NImaging dish used to seed cells for staining experiments
(1-42) 1 mgAnaSpec#64129Oligomers of amyloid beta to treat the cells
Alexa flour 488 Goat Anti-rabbit IgG (H+L)InvitrogenA11070Secondary antibody for phospho-PAK1
Biological Safety CabinetThermo Scientific (MSC Advantage)51025411Provide aspetic conditions duirng cell culture
CO2 IncubatorThermo Electron Corporation (Heraeus Hera Cell 240)51026556For growing cells at or near body temperature
Confocal Laser Scanning MicroscopeZEISS (Carl Zeiss)LSM 880Able to generate three-dimensional images of large specimen at super-resolution
DABCO [1,4-Diazobicyclo-(2,2,2) octane]Merck8034560100Anti-bleaching reagent
DAPI (4′,6-diamidino-2-phenylindole)SigmaD9542-1MGNeuclear stainer
DMEM mediaGibco11965092Used for the preparation of 100uM of Aβ (1-42)
 DMEM/F12 (1:1 mixture of DMEM and Ham’s F12)Gibco12500062Culture media for SH-SY5Y
DMSO (Dimethyl sulphide) Cell culture gradeCryopurCP-100Cell culture grade used as dissolving agent for Retinoic acid
DMSO (Dimethyl sulphide) Molecular gradeHimediaMB058Used as one of the dissolving agent for the lyophilized Aβ (1-42)
Fetal Bovine SerumGibco16000044 Major supplement for Culture media (US origin)
Formalin Fixative (Neutral buffered 10%)Sigma AldrichHT5014-120MLComponent in the Karnovsky's fixative solution
Glutaraldehyde (Grade I, 25% in H2O)SigmaG5882Component in the Karnovsky's fixative solution
HFIP (1,1,1,3,3,3-hexafluoro-2-propanol ) solutionTCIH024Used to dissolve Aβ (1-42) 1 mg
Image Processing/ Analysis Software: FIJI (ImageJ)National Institute of Health (NIH)Used to process/analyze the images and to differentiate the TNTs from neurites using its plugin named "volume viewer".
LyophilizerChrist, Alpha2.4 LDplus0.05 mg aliquots of Aβ (1-42) can be stored in -20 °C after lyophilization only
Penicillin-Streptomycin-Neomycin MixtureThermo fisher Scientific15640055Antibiotic mixture
Phalloidin-iFlor 555Abcamab176756F-actin binding stain
Phospho-PAK1 (Thr423) /PAK2 (Thr402) [Rabbit]CST#2601Primary antibody
Polyclonal Antibody to Tubulin Beta 3 (TUBb3)Cloud clonePAE711Hu01Primary antibody
Retinoic acidSigma-AldrichR2625-50MGDifferentiating reagent
SaponinMerck8047-15-2Detergent used in the Incubation buffer in immunostaining
Water bath sonicator (Quart, Drain valve Heater)Ultrasonic Cleaner3.0 L/3.2Sonicator used to dissolve Aβ (1-42) stock, after DMSO adding to it during the preparation of 100 µM Aβ (1-42)
ZEN Microscopy softwareZEISS (Carl Zeiss)Imaging software to acquire confocal microscopy images with smart automation

References

  1. Rustom, A., Saffrich, R., Markovic, I., Walther, P., Gerdes, H. H. Nanotubular highways for intercellular organelle transport. Science. 303 (5660), 1007-1010 (2004).
  2. Desir, S., et al. Chemotherapy-induced tunneling nanotubes mediate intercellular drug efflux in pancreatic cancer. Scientific Reports. 8, 9484 (2018).
  3. Cordero Cervantes, D., Zurzolo, C. Peering into tunneling nanotubes-The path forward. The EMBO Journal. 40 (8), 105789 (2021).
  4. Dieriks, B. V., et al. α-synuclein transfer through tunneling nanotubes occurs in SH-SY5Y cells and primary brain pericytes from Parkinson's disease patients. Scientific Reports. 7, 42984 (2017).
  5. Chen, J., Cao, J. Astrocyte-to-neuron transportation of enhanced green fluorescent protein in cerebral cortex requires F-actin dependent tunneling nanotubes. Scientific Reports. 11, 16798 (2021).
  6. Mittal, R., et al. Cell communication by tunneling nanotubes: Implications in disease and therapeutic applications. Journal of Cellular Physiology. 234 (2), 1130-1146 (2019).
  7. Polak, R., de Rooij, B., Pieters, R., den Boer, M. L. B-cell precursor acute lymphoblastic leukemia cells use tunneling nanotubes to orchestrate their microenvironment. Blood. 126 (21), 2404-2414 (2015).
  8. Panasiuk, M., Rychlowski, M., Derewonko, N., Bienkowska-Szewczyk, K. Tunneling nanotubes as a novel route of cell-to-cell spread of herpesviruses. Journal of Virology. 92 (10), 00090 (2018).
  9. Austefjord, M. W., Gerdes, H. H., Wang, X. Tunneling nanotubes: Diversity in morphology and structure. Communicative & Integrative Biology. 7 (1), 27934 (2014).
  10. Han, X., Wang, X. Opportunities and challenges in tunneling nanotubes research: How far from clinical application. International Journal of Molecular Sciences. 22 (5), 2306 (2021).
  11. Zurzolo, C. Tunneling nanotubes: Reshaping connectivity. Current Opinion in Cell Biology. 71, 139-147 (2021).
  12. Dilna, A., et al. Amyloid-beta induced membrane damage instigates tunneling nanotube-like conduits by p21-activated kinase dependent actin remodulation. Biochimica et Biophysica Acta (BBA)- Molecular Basis of Disease. 1867 (12), 166246 (2021).
  13. Chang, M., et al. Formation of cellular close-ended tunneling nanotubes through mechanical deformation. Science Advances. 8 (13), (2022).
  14. Bukoreshtliev, N. V., et al. Selective block of tunneling nanotube (TNT) formation inhibits intercellular organelle transfer between PC12 cells. FEBS Letters. 583 (9), 1481-1488 (2009).
  15. Zhang, J., et al. Direct observation of tunneling nanotubes within human mesenchymal stem cell spheroids. The Journal of Physical Chemistry B. 122 (43), 9920-9926 (2018).
  16. Hanna, S. J., et al. The role of Rho-GTPases and actin polymerization during Macrophage Tunneling Nanotube Biogenesis. Scientific Reports. 7, 8547 (2017).
  17. Raghavan, A., Rao, P., Neuzil, J., Pountney, D. L., Nath, S. Oxidative stress and Rho GTPases in the biogenesis of tunnelling nanotubes: Implications in disease and therapy. Cellular and Molecular Life Sciences. 79, 36 (2021).
  18. Abounit, S., Delage, E., Zurzolo, C. Identification and characterization of tunneling nanotubes for intercellular trafficking. Current Protocols in Cell Biology. 67, 11-21 (2015).
  19. Hodneland, E., et al. Automated detection of tunneling nanotubes in 3D images. Cytometry A. 69 (9), 961-972 (2006).
  20. Wang, X., Bukoreshtliev, N. V., Gerdes, H. H. Developing neurons form transient nanotubes facilitating electrical coupling and calcium signaling with distant astrocytes. PLoS One. 7 (10), 47429 (2012).
  21. Nath, S., et al. Spreading of neurodegenerative pathology via neuron-to-neuron transmission of beta-amyloid. Journal of Neuroscience. 32 (26), 8767-8777 (2012).
  22. Domert, J., et al. Spreading of amyloid-beta peptides via neuritic cell-to-cell transfer is dependent on insufficient cellular clearance. Neurobiology of Disease. 65, 82-92 (2014).
  23. Pawley, J. B., Pawley, J. B. Points, Pixels, and Gray Levels: Digitizing Image Data. Handbook Of Biological Confocal Microscopy. , 59-79 (2006).
  24. Pontes, B., et al. Structure and elastic properties of tunneling nanotubes. European Biophysics Journal. 37 (2), 121-129 (2008).
  25. Haimovich, G., Gerst, J. E. Detection of mRNA transfer between mammalian cells in coculture by single-molecule fluorescent in situ hybridization (smFISH). Methods in Molecular Biology. 2038, 109-129 (2019).
  26. Janardhan, K. S., Jensen, H., Clayton, N. P., Herbert, R. A. Immunohistochemistry in investigative and toxicologic pathology. Toxicologic Pathology. 46 (5), 488-510 (2018).
  27. Qin, Y., et al. The combination of paraformaldehyde and glutaraldehyde is a potential fixative for mitochondria. Biomolecules. 11 (5), 711 (2021).
  28. Graham, R. C., Karnovsky, M. J. The histochemical demonstration of monoamine oxidase activity by coupled peroxidatic oxidation. Journal of Histochemistry & Cytochemistry. 13 (7), 604-605 (1965).

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

Tunneling NanotubesDetectionQuantification3D Volume ImagesAutomatic Detection MethodsManual DetectionNeurodegenerative PathologyViral SpreadingCancerFixation ProtocolKarnovsky s FixativeIncubation BufferPhospho PAK1 AntibodyAlexa Fluor 488Phalloidin 555DAPI StainingDABCO Mounting Medium

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved